NZ614173B2 - Synthesis of 2-carboxamide cycloamino urea derivatives - Google Patents
Synthesis of 2-carboxamide cycloamino urea derivatives Download PDFInfo
- Publication number
- NZ614173B2 NZ614173B2 NZ614173A NZ61417312A NZ614173B2 NZ 614173 B2 NZ614173 B2 NZ 614173B2 NZ 614173 A NZ614173 A NZ 614173A NZ 61417312 A NZ61417312 A NZ 61417312A NZ 614173 B2 NZ614173 B2 NZ 614173B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- formula
- solvent
- contacting
- tetrahydrofuran
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title description 5
- 238000003786 synthesis reaction Methods 0.000 title description 5
- 230000002194 synthesizing Effects 0.000 title description 5
- 150000003672 ureas Chemical class 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 159
- 238000000034 method Methods 0.000 claims abstract description 41
- 239000002904 solvent Substances 0.000 claims description 122
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 100
- ZCSHNCUQKCANBX-UHFFFAOYSA-N Lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 48
- 239000011541 reaction mixture Substances 0.000 claims description 44
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 43
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 29
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-Bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 28
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 24
- 229910052736 halogen Inorganic materials 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 239000007800 oxidant agent Substances 0.000 claims description 18
- 150000001412 amines Chemical class 0.000 claims description 14
- 125000005843 halogen group Chemical group 0.000 claims description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 11
- UMGDCJDMYOKAJW-UHFFFAOYSA-N Thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 7
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 6
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 125000005914 C6-C14 aryloxy group Chemical group 0.000 claims description 2
- VRLDVERQJMEPIF-UHFFFAOYSA-N DBDMH Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 10
- 239000000543 intermediate Substances 0.000 abstract description 9
- OAWXZFGKDDFTGS-BYPYZUCNSA-N (2S)-pyrrolidine-1,2-dicarboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(O)=O OAWXZFGKDDFTGS-BYPYZUCNSA-N 0.000 abstract description 3
- STUWGJZDJHPWGZ-LBPRGKRZSA-N (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide Chemical compound S1C(C=2C=C(N=CC=2)C(C)(C)C(F)(F)F)=C(C)N=C1NC(=O)N1CCC[C@H]1C(N)=O STUWGJZDJHPWGZ-LBPRGKRZSA-N 0.000 abstract 4
- 229950010482 alpelisib Drugs 0.000 abstract 2
- AMNZAIQZZGVQJJ-UHFFFAOYSA-N S1C(=NC=C1)C1(N(CCC1)C(=O)N)C(=O)N Chemical class S1C(=NC=C1)C1(N(CCC1)C(=O)N)C(=O)N AMNZAIQZZGVQJJ-UHFFFAOYSA-N 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
- -1 2,2,2-trifluoro-1,1-dimethyl-ethyl Chemical group 0.000 description 43
- 125000000217 alkyl group Chemical group 0.000 description 31
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 26
- 150000002367 halogens Chemical class 0.000 description 19
- 125000001424 substituent group Chemical group 0.000 description 18
- 125000003545 alkoxy group Chemical group 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 125000003118 aryl group Chemical group 0.000 description 12
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 12
- 125000004429 atoms Chemical group 0.000 description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
- 239000003849 aromatic solvent Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- YZCKVEUIGOORGS-OUBTZVSYSA-N deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 8
- 229910052805 deuterium Inorganic materials 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 8
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Chemical compound [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- 125000004104 aryloxy group Chemical group 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 125000004432 carbon atoms Chemical group C* 0.000 description 6
- 125000004122 cyclic group Chemical group 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 125000001153 fluoro group Chemical group F* 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000003880 polar aprotic solvent Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000005456 alcohol based solvent Substances 0.000 description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 5
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 125000005842 heteroatoms Chemical group 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-Methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N Chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- UAOMVDZJSHZZME-UHFFFAOYSA-N Diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-Chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N Nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 125000002015 acyclic group Chemical group 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- 230000005595 deprotonation Effects 0.000 description 4
- 238000010537 deprotonation reaction Methods 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 4
- 229940011051 isopropyl acetate Drugs 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical group CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 125000001544 thienyl group Chemical group 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N MeOtBu Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical group [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 3
- 229940035295 Ting Drugs 0.000 description 3
- 125000003282 alkyl amino group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 239000012296 anti-solvent Substances 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 150000007942 carboxylates Chemical group 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 description 3
- 125000001041 indolyl group Chemical group 0.000 description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 150000002829 nitrogen Chemical group 0.000 description 3
- 125000003373 pyrazinyl group Chemical group 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- SSUJUUNLZQVZMO-UHFFFAOYSA-N 1,2,3,4,8,9,10,10a-octahydropyrimido[1,2-a]azepine Chemical compound C1CCC=CN2CCCNC21 SSUJUUNLZQVZMO-UHFFFAOYSA-N 0.000 description 2
- OMIVCRYZSXDGAB-UHFFFAOYSA-N 1,4-butanediyl Chemical group [CH2]CC[CH2] OMIVCRYZSXDGAB-UHFFFAOYSA-N 0.000 description 2
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical group C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 description 2
- 108040005185 1-phosphatidylinositol-3-kinase activity proteins Proteins 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N Anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N Isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N Methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N Perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 description 2
- 102000003993 Phosphatidylinositol 3-Kinases Human genes 0.000 description 2
- 108090000430 Phosphatidylinositol 3-Kinases Proteins 0.000 description 2
- 229910006069 SO3H Inorganic materials 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N Sulfuryl chloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004947 alkyl aryl amino group Chemical group 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- 125000005128 aryl amino alkyl group Chemical group 0.000 description 2
- 125000001769 aryl amino group Chemical group 0.000 description 2
- 125000003725 azepanyl group Chemical group 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 239000012455 biphasic mixture Substances 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 2
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- PBGGNZZGJIKBMJ-UHFFFAOYSA-N di(propan-2-yl)azanide Chemical compound CC(C)[N-]C(C)C PBGGNZZGJIKBMJ-UHFFFAOYSA-N 0.000 description 2
- 125000004986 diarylamino group Chemical group 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 239000008079 hexane Substances 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229960004624 perflexane Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 150000003738 xylenes Chemical class 0.000 description 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 1
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 description 1
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 description 1
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 1
- CUJPFPXNDSIBPG-UHFFFAOYSA-N 1,3-propanediyl Chemical group [CH2]C[CH2] CUJPFPXNDSIBPG-UHFFFAOYSA-N 0.000 description 1
- KEFBAMRFXYKOBI-UHFFFAOYSA-N 1,4$l^{2}-thiazinane 1,1-dioxide Chemical group O=S1(=O)CC[N]CC1 KEFBAMRFXYKOBI-UHFFFAOYSA-N 0.000 description 1
- YZYQQJHFYIVWPS-UHFFFAOYSA-N 3,4,5,6-tetradehydrothiopyran Chemical group [CH]1SC#CC#C1 YZYQQJHFYIVWPS-UHFFFAOYSA-N 0.000 description 1
- YHPMRWZVIQTSFZ-UHFFFAOYSA-N 3,5-difluoro-2-(2-fluorophenyl)pyridine Chemical compound FC1=CC(F)=CN=C1C1=CC=CC=C1F YHPMRWZVIQTSFZ-UHFFFAOYSA-N 0.000 description 1
- 125000002471 4H-quinolizinyl group Chemical group C=1(C=CCN2C=CC=CC12)* 0.000 description 1
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- 241001091551 Clio Species 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N Inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 description 1
- 101710009221 LD Proteins 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229910004727 OSO3H Inorganic materials 0.000 description 1
- SLYCYWCVSGPDFR-UHFFFAOYSA-N Octadecyltrimethoxysilane Chemical compound CCCCCCCCCCCCCCCCCC[Si](OC)(OC)OC SLYCYWCVSGPDFR-UHFFFAOYSA-N 0.000 description 1
- 102000030951 Phosphotransferases Human genes 0.000 description 1
- 108091000081 Phosphotransferases Proteins 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N Succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- QHMQWEPBXSHHLH-UHFFFAOYSA-N Sulfur tetrafluoride Chemical compound FS(F)(F)F QHMQWEPBXSHHLH-UHFFFAOYSA-N 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N Tert-Butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N Trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000004171 alkoxy aryl group Chemical group 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005418 aryl aryl group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
- 125000005325 aryloxy aryl group Chemical group 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 125000004045 azirinyl group Chemical group 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000002051 biphasic Effects 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-M carbonochloridate Chemical compound [O-]C(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-M 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 125000005959 diazepanyl group Chemical group 0.000 description 1
- 125000005509 dibenzothiophenyl group Chemical group 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 125000005303 dithiazolyl group Chemical group S1SNC(=C1)* 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 108060003458 ftsY Proteins 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MVFGXYPEQHIKIX-UHFFFAOYSA-M heptane;acetate Chemical compound CC([O-])=O.CCCCCCC MVFGXYPEQHIKIX-UHFFFAOYSA-M 0.000 description 1
- 125000004475 heteroaralkyl group Chemical group 0.000 description 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- KLGZELKXQMTEMM-UHFFFAOYSA-N hydride Chemical compound [H-] KLGZELKXQMTEMM-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000003384 isochromanyl group Chemical group C1(OCCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N n-methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 description 1
- 125000005029 naphthylthio group Chemical group C1(=CC=CC2=CC=CC=C12)S* 0.000 description 1
- YIKSCQDJHCMVMK-UHFFFAOYSA-N oxalic acid diamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N oxygen atom Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atoms Chemical group O* 0.000 description 1
- 125000005327 perimidinyl group Chemical group N1C(=NC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N t-BuOH Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000004627 thianthrenyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3SC12)* 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000004001 thioalkyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 125000004933 β-carbolinyl group Chemical group C1(=NC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Provided herein are processes and intermediate compounds useful for the preparation of (1,3-Thiazol-2-yl)Pyrrolidine-1,2-Dicarboxamide Derivatives derivatives of formula (X), and useful intermediates (such as compounds of formula (V)) therefore. in particular synthetic methods for the preparation of (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide) (i.e., the compound of formula (10), alpelisib or BYL-719). also disclosed is compound (1) (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide) (i.e., the compound of formula (10), alpelisib or BYL-719). also disclosed is compound (1)
Description
SYNTHESIS OF 2-CARBOXAMIDE CYCLOAMINO UREA DERIVATIVES
FIELD OF INVENTION
The present invention is directed to processes for preparing oxamide cycloamino
urea derivatives, and useful intermediates therefore.
BACKGROUND
The processes of the present invention are useful for the preparation of alpha-selective
phosphatidylinositol (PI) 3-kinase inhibitor nds according to formula (X), and
intermediates therefore. Phosphatidylinositol 3-kinases (P13Ks) comprise a family of lipid
kinases that catalyze the transfer ofphosphate to the D-3' position of inositol lipids to produce
phosphoinositolphosphate (PIP), phosphoinositol-3,4—diphosphate (PIP2) and
phosphoinositol-3,4,5-triphosphate (PIP3), which, in turn, act as second gers in signaling
cascades by docking proteins containing pleckstrin—homology, FYVE, Phox and other
olipid-binding domains into a variety of signaling complexes often at the plasma
membrane.
PCT Publication No. discloses PI3K inhibitors. The compounds
sed therein include (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide l-( {4-methy1—5—[2-
(2,2,2-trifluoro-1,1-dimethyl—ethyl)-pyridinyl]-thiazolyl}-amide) (i.e., the compound of
a (10)). The present invention is directed to improved ses for preparing compounds
of the formula (X), specifically the compound of formula (10), as well as useful intermediates
such as nds of the formula (I), specifically the compound of formula (1):
N N
HN—\< NH2 NH2
N, O o
N, o 0
\ s 3
R2 \
H30 CH3 CH3
N/ / CF3 CF3
R1 N/ R1 N/
H30 CH3 H30 CH3
(X) (10) (l) (1)
SUMMARY OF THE INVENTION
Provided herein are processes for the preparation of compounds of formula (X). Also
provided herein are intermediate compounds, as well as methods of making those intermediates,
that are useful for the preparation of compounds of formula (X). The compounds of formulas
) and the compounds of formulas (1) to (8) and (10) refer to the compounds as defined in
the description herein.
In one aspect of the present invention, there is provided a process for making a compound
of formula (X):
N/ O 0
N R1
comprising the following steps:
Step A: contacting a compound of formula (I) with a solvent ydrofuran and a base
lithium diisopropylamide, and contacting the resulting mixture with a compound of formula (II)
at an internal ature of less than about -5°C to about -15°C, such that a compound of
formula (III) is produced:
(followed by page 2a)
CH3 R2
\ 0 \
/ )L ,OCH3 l
R2 '1‘ /
N R1 N R1
0) (II) (III)
Step B: contacting a compound of formula (III) with thiourea, in a reaction mixture
comprising a solvent selected from toluene, ethanol or a combination thereof and an oxidizing
agent N—bromosuccinimide, such that a nd of a (V) is produced:
Step C: contacting a compound of formula (V) with a compound of formula (VII), in a
reaction mixture comprising a solvent tetrahydrofuran and a base amine, such that a compound
of formula (VIII) is produced:
N/ O
O \
(VII) (VIII)
Step D: contacting a compound of formula (VIII) with the compound of a (IX),
(followed by page 2b)
0 H
(IX)
in a reaction mixture comprising a solvent selected from tetrahydrofuran, water or a combination
thereof, such that a compound of formula (X) is produced
wherein
R1 is a branched or linear C1-C7 alkyl, which may be optionally substituted one or more
times With deuterium, halogen, or C3-C5 cycloalkyl,
R2, is methyl
R3 is halogen,
R4 is C6-C14 aryloxy and
X is a halide.
In a further aspect of the present invention, there is provided a s for making the
compound of formula (10):
N/ cF3
H3C CH3
(10)
comprising the following steps:
M: contacting the nd of formula (1) with a solvent tetrahydrofuran and a
base lithium diisopropylamide, and contacting the resulting mixture with the compound of
formula (2) at an internal temperature of less than about -5°C to about -15°C, such that the
compound of a (3) is ed:
(followed by page 20)
CH3 H30
\ 0 \
'N/ CF3 HstLlfl’OCHs’ 'N/ CF3
H3C CH3 CH3 H30 CH3
(1) (2) (3) ;
Step B: contacting the compound of formula (3) with thiourea, in a reaction mixture
comprising a solvent ed from toluene, l or a combination thereof and an oxidizing
agent N-bromosuccinimide, such that the compound of formula (5) is produced:
Step C: contacting the compound of formula (5) with the nd of formula (7), in a
reaction mixture comprising a solvent tetrahydrofiiran and a base amine, such that the compound
of formula (8) is produced:
N/ 0
<1 ° '\
OACI N/ CF3
H30 CH3
(7) (3) ;and
Step D: contacting the compound of formula (8) with the compound of formula (IX)
(followed by page 2d)
0 H
(IX)
in a reaction mixture comprising a solvent selected from tetrahydrofuran, water or a combination
f, such that the compound of formula (10) is produced.
Also described herein is a process for making a compound of a (V)
- HX
N R1
comprising contacting a nd of formula (I) with a solvent and a base and contacting the
resulting mixture with a compound of formula (11), such that a compound of a (III) is
produced (STEP A). The compound of formula (III) is then contacted with thiourea, in a
reaction mixture comprising a solvent and an oxidizing agent, such that a compound of formula
(V) is produced (STEP B).
(followed by page 3)
Also described herein is a process for making a nd of formula (X)
N/ O 0
N R1
comprising contacting a nd of formula (V) with a compound of formula (VII), in a
reaction mixture comprising a solvent and a base, such that a compound of a (VIII) is
produced (STEP C). The compound of formula (VIII) is then contacted with the compound of
formula (IX) in a reaction mixture comprising a solvent, such that a compound of formula (X) is
produced (STEP D).
In still another aspect, provided herein is a process for making a compound of formula
(X), comprising contacting a compound of formula (I) with a solvent and a base, and ting
the resulting mixture with a compound of formula (11), such that a compound of formula (III) is
produced (STEP A); contacting a compound of formula (III) with thiourea, in a reaction mixture
comprising a solvent and an oxidizing agent, such that a compound of formula (V) is produced
(STEP B); contacting a compound of formula (V) with a compound of formula (VII), in a
reaction e comprising a solvent and a base, such that a compound of formula (VIII) is
produced (STEP C); and contacting a compound of formula (VIII) with the nd of
formula (IX) in a reaction mixture comprising a solvent, such that a compound of formula (X) is
produced (STEP D).
In accordance with the t invention, the solvent of Step A comprises one or more
ts selected from aromatic solvents, aliphatic solvents, halogenated solvents, polar aprotic
ts and ethereal solvents.
In accordance with the present invention, the solvent of Steps B, C and D independently
comprises one or more solvents selected from aromatic solvents, aliphatic solvents, halogenated
solvents, ethereal solvents, polar aprotic solvents, water and alcohol solvents.
Also described herein is a process for making the compound of formula (10), comprising
contacting the compound of formula (1) with a solvent and a base, and contacting the resulting
mixture with a compound of formula (2), such that the compound of a (3) is produced
(STEP A). The compound of formula (3) is then contacted with thiourea, in a reaction mixture
comprising a t and an ing agent, such that the nd of formula (5) is produced
(STEP B). The compound of formula (5) is next contacted with the compound of formula (7), in
a reaction mixture comprising a t and a base, such that the nd of formula (8) is
produced (STEP C). Finally, the compound of formula (8) is contacted with the compound of
formula (IX), in a reaction mixture comprising a solvent, such that the compound of formula (10)
is produced (STEP D).
In one embodiment of the synthesis of the compound of formula (10), the solvent of Step
A comprises ydrofuran, the base of Step A is lithium diisopropylamide, the solvent of Step
B comprises toluene and ethanol, the oxidizing agent of Step B is N-bromosuccinimide, the
solvent of Step C comprises tetrahydrofuran, the base of Step C is pyridine and the solvent of
Step D comprises tetrahydrofuran and water.
In a r aspect of the t invention, there is provided a compound according to
a (1).
DETAILED DESCRIPTION
Provided herein are processes and intermediate compounds useful for the preparation of
PI3K inhibitors. These processes are advantageous over previously—known processes (see, e.g.,
PCT Publication No. ) in several ways. For e, the instant processes do
not employ transition metal-catalyzed reactions, and therefore do not require steps to remove
transition metal byproducts, es and impurities. Additionally, the instant processes do not
require reactions to be performed at very low temperatures (e.g., —78 °C).
2012/053559
In one aspect of the present invention, ed herein is a
process for making
a compound of formula (V), sing the following steps:
Step A: contacting a compound of formula (I) with a solvent and a base, and
contacting the resulting mixture with a compound of a (11), such that a compound
of formula (III) is produced:
CH3 1. Base R2
\ \
I, 2. O I/
N R1 )L ,OCH3 N
R2 r}:
CH3 ; then H30+
(I) (II) (III)
; and
Step B: contacting a compound of formula (III) with thiourea, in a reaction
mixture comprising a solvent and an oxidizing agent [X+], such that a compound of
formula (V) is produced:
o N:(
s \ 3
R2 JL R2
H2N NH2
\ \
I I
N/ R1 N’ R
[x+] 1
(III) (V)
wherein R1 is a cyclic or acyclic, branched or linear C1-C7 alkyl, which
may be
optionally substituted one or more times with deuterium, halogen, or C3-C5 cycloalkyl;
wherein R2 is selected from (1) hydrogen, (2) fluoro, chloro, (3) optionally
substituted methyl, wherein said substituents are independently selected from one or
more, preferably one to three of the following moieties: ium, fluoro, chloro,
dimethylamino; and
wherein X is selected from the group consisting of halide, carboxylate and
sulfonate.
In another aspect, provided herein is a
process for making a compound of formula
(X), comprising the following steps:
Step C: contacting a compound of formula (V) with a compound of formula (VII),
in a reaction mixture sing a solvent and a base, such that
a compound of formula
(VIII) is produced:
NH?- R3
N..— O
R2 \ 3
. HX R2
I O \
/ I
N R1 R3JLR4 /
N R1
Step D: contacting a compound of a (VIII) with the compound of formula
(IX), in a reaction mixture comprising a solvent, such that a nd of foxmula (X) is
produced:
M") (X)
wherein R1 is a cyclic or acyclic, branched or linear C1-C7 alkyl, which
may be
optionally substituted one or more times with deuterium, halogen, or C3-C5 cycloalkyl;
and
wherein R2 is selected from (1) hydrogen, (2) fluoro, chloro, (3) ally
tuted methyl, wherein said substituents are independently selected from
one or
W0 2012/117071
more, preferably one to three of the following moieties: deuterium, fluoro, chloro,
dimethylamino; and
wherein X is selected from the
group ting of halide, carboxylate and
sulfonate; and
wherein R3 and R4 are ndently selected from the
group consisting of
halogen, heteroaryl, alkoxy and aryloxy; and
wherein the heteroaryl, alkoxy and y moieties of
R3 and R4 are optionally,
ndently substituted one or more times with alkyl, alkoxy, halogen and nitro.
In still another aspect, provided herein is
a process for making a compound of
formula (X), comprising the following
steps:M3 contacting a compound of formula
(I) with a solvent and a base, and contacting the ing mixture with
a compound of
formula (II), such that a compound of formula (III) is
produced;M: contacting a
nd of formula (III) with thiourea, in a reaction mixture comprising
a solvent and
an oxidizing agent, such that a compound of formula (V) is produced;M:
contacting
a compound of formula (V) with a compound of formula (VII), in
a on mixture
comprising a solvent and a base, such that a nd of formula (VIII) is produced; and
M: contacting a compound of formula (VIII) with the compound of formula
(IX), in
a reaction mixture comprising a solvent, such that
a compound of formula (X) is
produced; wherein R1, R2, R3, R4 and X are as defined above.
In accordance with the present invention, the solvent of
Step A comprises one or
more solvents selected from aromatic ts, aliphatic solvents, halogenated
solvents,
polar aprotic solvents and ethereal solvents. Numerous examples ofthese solvents
known to those with skill in the art. Non-limiting
examples of aromatic solvents include
benzene, toluene, xylenes, nitrobenzene, anisole, ethylbenzene, and pyridine. Non-
ng examples of tic solvents include petroleum ether, ligroin, n-hexane,
cyclohexane and heptane. Non-limiting examples of halogenated solvents include
chloroform, chlorobenzene and perfluorohexane. Non-limiting examples of
polar aprotic
solvents include dimethylsulfoxide, dimethylformamide and
N-methyl idone. Non-
limiting examples of ethereal solvents include l ether, methyl tertiary-butyl
ether,
tetrahydrofuran, 2-methyl ydrofuran and oxyethane. In certain embodiments,
2012/053559
the solvent of Step A is an c, organic solvent. In preferred embodiments, the
t of Step A comprises tetrahydrofuran.
In accordance with the present invention, the solvent of Steps B, C and D
independently comprises one or more solvents selected from ic solvents, aliphatic
solvents, halogenated solvents, ethereal solvents, polar aprotic solvents, water and
alcohol solvents. miting examples ofalcohol solvents include ethanol, tertiary-
l and ethylene glycol. Other alcohol solvents are known to those skilled in the art.
In certain embodiments, the solvent of Step B comprises
an aromatic solvent and an
alcohol solvent. In a preferred embodiment, the solvent of Step B comprises toluene and
ethanol. In n embodiments, the solvent of Step C comprises
an ethereal solvent. In
a preferred embodiment, the solvent of Step C comprises tetrahydrofuran. In certain
embodiments, the solvent of Step D comprises and al solvent and water. In a
preferred embodiment, the solvent of Step D comprises tetrahydrofuran and water.
In accordance with the present invention, the base of Step A is
a strong base.
Strong bases include the conjugate bases ocarbons, ammonia, amines and
dihydrogen. Non-limiting examples of strong bases include n-butyllithium, n-
hexyllithium, sodium hydride and lithium diisopropylamide. Other strong bases are
known to those skilled in the art. In certain ments, the base of Step A is lithium
diisopropylamide. Methods ofpreparing lithium diisopropylamide are known to those of
skill in the art (see, e.g., Smith, A. P.; Lamba, J. J. 8.; Fraser, C. L., Org. Syn. Col.
Vol.
: 107, (2004)). In one embodiment, the lithium diisopropylamide is prepared by the
deprotonation of isopropylamine with an alkyllithium base such as llithium, n-
hexyllithium or n-octyllithium. Safety and economic considerations may influence the
selection of reagents used for the preparation of lithium diisopropylamide (see,
e. g.,
Chapter 3: t Selection, in "Practical Process Research and Development",
ic Press, 2000). In one embodiment, the lithium diisopropylamide is prepared by
the deprotonation ofdiisopropylamine with n-hexyllithium. One of skill in the
art would
understand that solutions of lithium diisopropylamide in certain solvents, such
as THF,
should be maintained at temperatures equal to or below 0 °C.
W0 2012/117071 2012/053559
In one embodiment ofthe above
processes, the base of Step C is an amine. Non-
limiting examples of amine bases include tertiary-butylamine, piperidine, triethylamine,
1,8-Diazabicyclo[5.4.0]undecene and pyridine. Other amine bases are known to those
skilled in the art. In n embodiments, the base of Step C is pyridine.
In accordance with the t invention, the oxidizing
agent of Step B is an
electrophilic halogen reagent. Numerous ophilic halogen reagents are known to the
skilled practitioner, including dibromine, diiodine, dichlorine, sulfuryl chloride, N-
bromosuccinimide, succinimide, N-chlorosuccinimide and l,3-dibromo—5,S-
dimethylhydantoin. In certain embodiments, the oxidizing agent of Step B is N-
bromosuccinimide.
In one embodiment ofthe present invention, the oxidizing
agent of Step B is N-
bromosuccinimide, and the subsequent mixture is diluted with an olvent agent. In a
preferred ment, the anti-solvent is pyl acetate.
In accordance with the the present invention, X is selected from the
group
consisting of halide, carboxylate, and sulfonate. In certain embodiments, X is a halide.
In a red embodiment, X is bromine.
In a preferred embodiment ofthe above
processes, the solvent of Step A
comprises tetrahydrofuran, the base of Step A is lithium diisopropylarnide, the solvent of
Step B comprises toluene and ethanol, the oxidizing agent of Step B is N-
bromosuccinimide, the solvent of Step C comprises tetrahydrofiiran, the base of Step C is
pyridine and the solvent of Step D comprises tetrahydrofuran and water.
In various embodiments ofthe above
processes, R; is a cyclic or acyclic,
branched or linear C1-C7 alkyl, all of which
may be optionally substituted one or more
times with deuterium, halogen, or C3-C5 cycloalkyl. In other embodiments, R1 is a
branched or linear C1-C7 alkyl that is optionally substituted one
or more times with
mCF3 halogen. In a red embodiment, R1 is H3O
In s embodiments ofthe above
processes, R2 represents (1) hydrogen, (2)
fluoro, chloro, (3) optionally substituted methyl, wherein said substituents are
independently selected from one or more, preferably one to three of the following
es: deuterium, fluoro, chloro, dimethylamino. In certain ments, R2 is
selected from hydrogen, cyclic or acyclic, branched or linear C1-C7 alkyl, and halogen
wherein the alkyl is optiOnally substituted one or more times with deuterium, fluorine,
chlorine and dimethylamino. In other embodiments, R2 is a branched or linear C1-C7
alkyl. In a preferred embodiment, R2 is methyl.
In various embodiments, R3 and R4 are independently ed from the
group
consisting of halogen, heteroaryl, alkoxy and aryloxy; wherein the heteroaryl, alkoxy and
aryloxy moieties ofR3 and R4 are ally, independently substituted one or more times
with alkyl, alkoxy, halogen and nitro. In certain embodiments, R3 is aryloxy and R4 are
both heteroaryl. In other embodiments, R3 is aryloxy and R4 is halogen.
. In a preferred
embodiment, R3 is phenoxy and R4 is chlorine.
\93KCF3
In a preferred embodiment of the above. . CH3
processes, R1 is H3O , R2 15 methyl,
R3 is phenoxy, R4 is chlorine and X is bromine.
In one embodiment ofthe present invention, the nd of formula (I) is first
contacted with the compound of a (II) in a reaction mixture comprising
a base and
t, and second optionally contacted with a reaction mixture sing an
aqueous
acid or base resulting in the pH of the
aqueous phase to be within the range 2 < pH < 4,
preferably pH 3. Preferably, the base is lithium diisopropylamide and the first solvent is
THF, wherein the reaction mixture is maintained such that the internal ature
remains less than -5°C, preferably at -15°C. ably, the pH of the aqueous phase is
adjusted to pH 3 with a reaction mixture comprising sulfuric acid, water and toluene.
In one embodiment ofthe present invention, the compound of formula (VIII) is
contacted with the compound of formula (IX) in a reaction mixture comprising
a first
solvent, such that the compound of a (X) is formed. An aromatic solvent is then
added to the mixture, followed by removal of the first solvent by distillation, resulting in
the precipitation of the compound of formula (X). Preferably, the aromatic solvent is
toluene.
In another aspect of the present invention, provided herein is
a process for making
the compound of formula (10), sing the following
steps:
Step A: contacting the compound offormula (1) with a solvent and a base, and .
contacting the resulting mixture with the compound of formula (2), such that the
compound of formula (3) is produced:
CH3‘
1. Base H3O
l \
/ CF3 2- 0 l
N JK / CF3
CH3 ,OCH3 N
H30 H30 '3 H3C CH3
CH3 ; then H3O+
(1) (2) (3)
Step B: contacting the nd of formula (3) with thiourea, in a reaction
mixture comprising a solvent and an oxidizing agent [Br+], such that the
compound of
formula (5) is produced:
0 N=(
H30 \ 3
JL H30
_ HBr
\ HZN NH2
l \
/ CF3 l
N CFa
H30 CH3 “3”]
H30 CH3
(3) (5)
Step C: contacting the compound of formula (5) with the compound of formula
(7), in a on mixture comprising a solvent and a base, such that the compound of
formula (8) is produced:
‘HBr H3C
l \
CF3 (Z) N/ . l
N/ CF3
H30 CH3
H3O CH3
(5) (8) ;and
Step D: contacting the compound offormula (8) with the compound of formula
(IX), in a reaction mixture sing a solvent, such that the compound of formula (10)
is produced:
HN—<°@ 0 I'd HN—< ”“2
s 2
\ s
H3C \
(IX)
I \
-———~ I
N/ CF3 N/ CF3
H3C CH3 H30 CH3
(8) (10) .In accordance
with this aspect of the present invention, the t of Step A comprises
one or more
solvents selected from ic solvents, aliphatic solvents, halogenated solvents, polar
aprotic solVents and ethereal solvents. us examples of these solvents are known
to those with skill in the art. Non-limiting examples of aromatic solvents include
benzene, toluene, xylenes, nitrobenzene, anisole, ethylbenzene, and pyridine. Non-
ng examples of aliphatic ts include petroleum ether, ligroin, n—hexane,
cyclohexane and heptane. Non-limiting examples of halogenated solvents include
chloroform, chlorobenzene and perfluorohexane. miting examples ofpolar aprotic
solvents include dimethylsulfoxide, dimethylformamide and N-methyl pyrrolidone. Non-
limiting examples of ethereal ts include diethyl ether, methyl tertiary-butyl ether,
tetrahydrofuran, 2-methyl tetrahydrofuran and dimethoxyethane. In certain embodiments,
W0 2012/117071 2012/053559
the solvent of Step A is an aprotic, organic solvent.
In preferred embodiments, the
t of Step A comprises tetrahydrofuran.
In accordance with this aspect ofthe
present invention, the solvent of Steps B, C
and D independently comprises one
or more solvents selected from aromatic solvents,
aliphatic solvents, halogenated solvents, ethereal solvents, polar
aprotic solvents, water
and alcohol ts. Non-limiting examples of alcohol
solvents include ethanol,
tertiary-butanol and ne glycol. Other alcohol solvents are known to those skilled in
the art. In certain embodiments, the solvent of Step
B comprises an aromatic t and
an alcohol solvent. In a preferred embodiment, the solvent of Step B
comprises toluene
and ethanol. In certain embodiments, the solvent of Step C
comprises an ethereal solvent.
In a preferred embodiment, the solvent of Step C
comprises ydrofuran. In certain
embodiments, the solvent of Step D comprises and ethereal solvent and
water. In a
preferred embodiment, the solvent of Step D comprises tetrahydrofuran and
water.
In accordance with this aspect of the
present invention, the base of Step A is a
strong base. Strong bases include the conjugate bases of hydrocarbons, ammonia, amines
and dihydrogen. Non-limiting examples of
strong bases include n-butyllithium, n-
hexyllithium, sodium hydride and m diisopropylamide. Other
strong bases are
known to those skilled in the art. In n embodiments, the base of Step A is m
diisopropylamide. Methods ofpreparing lithium diisopropylamide are known
to those of
skill in the art (see, e.g., Smith, A. P.; Lamba, J. J.
8.; Fraser, C. L., Org. Syn. Col. Vol.
: 107, ). In one ment, the lithium diisopropylamide
is prepared by the
deprotonation of isopropylamine with an alkyllithium base such
as llithium, n—
hexyllithium or n-octyllithium. Safety and economic considerations may influence the
selection of reagents used for the preparation of lithium
diisopropylamide (see, e.g.,
Chapter 3: Reagent Selection, in "Practical Process Research and Development",
Academic Press, 2000). In one embodiment, the lithium diisopropylamide
is prepared by
the deprotonation ofdiisopropylamine with n-hexyllithium.
One of skill in the art would
understand that solutions of lithium diisopropylamide in
certain ts, such as THF,
should be maintained at temperatures equal to
or below 0 °C.
In a further embodiment ofthe above
processes of the present invention, the base
of Step C is an amine. Non-limiting examples of amine bases e ry-butylamine,
piperidine, triethylamine, 1,8-Diazabicyclo[5.4.0]undecene and pyridine. Other amine
bases are known to those skilled in the art. In certain embodiments, the base of Step C is
In one embodiment ofthe above
processes of the present invention, the oxidizing
agent of Step B is an electrophilic halogen reagent. Numerous ophilic halogen
reagents are known to the skilled practitioner, including dibromine, diiodine, rine,
sulfuryl chloride, N-bromosuccinimide, N-iodosuccinimide, N-chlorosuccinimide and
bromo-5,S-dimethylhydantoin. In certain embodiments, the oxidizing
agent of Step
B is N-bromosuccinimide.
In one embodiment ofthe present invention, the oxidizing
agent of Step B is N—
bromosuccinimide, and the subsequent mixture is diluted with an anti-solvent
agent. In a
red ment, the anti-solvent is isopropyl acetate.
In a preferred embodiment of the synthesis of the compound of formula
(10), the
t of Step A comprises tetrahydrofuran, the base of Step A is lithium
diisopropylamide, the solvent of Step B comprises toluene and ethanol, the oxidizing
agent of Step B is N—bromosuccinimide, the solvent of Step C comprises tetrahydrofuran,
the base of Step C is pyridine and the solvent of Step D
ses tetrahydrofuran and
water.
In one embodiment ofthe present invention, the compound of formula
(1) is first
contacted with the compound of formula (2) in a reaction e
comprising a base and
solvent, and second optionally contacted with a reaction mixture comprising
an aqueous
acid or base ing in the pH of the
s phase to be within the range 2 < pH < 4,
preferably pH 3. Preferably, the base is lithium diisopropylamide and the first solvent is
THF, wherein the reaction mixture is maintained such that the internal
temperature
remains less than -5°C, preferably at -15°C. Preferably, the pH of the aqueous phase is
adjusted to pH 3 with a reaction mixture comprising sulfuric acid, water and toluene.
In one embodiment ofthe present invention, the compound of formula
(5) is
contacted with the compound of formula (7) in a reaction mixture comprising
the solvent
W0 2012/117071
THF and the base pyridine, and then the base pyridine is removed by addition
saturated saline or aqueous salt (preferably sodium chloride) solution. In
one embodiment
ofthe t invention, the compound of formula (8) is contacted with the
compound of
formula (IX) in a reaction mixture sing a first t, such that the
nd of
formula (10) is formed. An aromatic solvent is then added to the mixture,
followed by
removal of the first t by distillation, resulting in the precipitation of the
compound
of formula (10). Preferably, the ic solvent is toluene.
In another aspect of the invention, provided herein is
a compound according to
formula (1):
N/ CF3
H3C CH3
The compound of a (1) is particularly useful
as a starting material, or an
intermediate, in the preparation of the compound of formula (10), as well as chemical
analogues of the compound of formula (10). The compound of formula (1) can be
synthesized in accordance with the preparation methods set forth in Scheme 4 or Scheme
herein.
The skilled practitioner will recognize several
parameters of the foregoing
processes that may be varied advantageously in order to obtain a desirable outcome.
These ters include, for example, the methods and
means ofpurification of on
components and solvents; the order of addition of said reaction components and solvents
to the reaction mixture; the duration of reaction of said reaction
components and solvents;
and the temperature and rate of stirring, mixing or agitation of the on
components
and solvents during said reaction.
Definitions
W0 2012/117071
As used herein, the term “lower” or “Cl-C7” denotes a radical having up to and
including a maximum of 7, especially up to and including a maximum of 4 carbon atoms,
the radicals in question being either linear or branched with single or multiple ing.
As used herein, the term ” refers to a straight-chain or ed-chain alkyl
group, preferably represents a straight-chain or branched-chain €1-12alkyl, particularly
ably represents a straight-chain or branched-chain kyl; for example, methyl,
ethyl, n- or opyl, n-, iso-, sec- or tert—butyl, n-pentyl, n-hexyl, n—heptyl, n-octyl, nnonyl
, n-decyl, n-undecyl, n-dodecyl, with particular ence given to methyl, ethyl, n-
propyl, iso-propyl and n-butyl and iso-butyl. Alkyl may be unsubstituted or substituted.
Exemplary substituents include, but are not d to deuterium, hydroxy, alkoxy, halo
and amino. An example of a substituted alkyl is trifluoromethyl. Cycloalkyl may also be
a substituent to alkyl. An example of such a case is the moiety (alkyl)-cyclopropyl or
alkandiyl-cycloproyl, e.g. —CH2-cyclopropyl. C1-C7-alkyl is preferably alkyl with from
and including 1 up to and including 7, preferably from and including 1 to and including 4,
and is linear or branched; preferably, lower alkyl is butyl, such as n-butyl, sec-butyl,
isobutyl, tert—butyl, propyl, such as n-propyl or isopropyl, ethyl or preferably methyl.
Each alkyl part of other groups like “alkoxy”, “alkoxyalkyl”, “alkoxycarbonyl”,
“alkoxy-carbonylalkyl”, “alkylsulfonyl”, “alkylsulfoxyl”, “alkylamino”, “haloalkyl” shall
have the same meaning as described in the above-mentioned definition of “alkyl”
As used herein, the term “alkandiyl” refers to a straight-chain or branched-chain
alkandiyl group bound by two different Carbon atoms to the moiety, it preferably
represents a straight-chain or branched-chain C 1.12 alkandiyl, particularly ably
ents a straight-chain or branched-chain CM, alkandiyl; for example, methandiyl;(-
CH2-), 1,2-ethanediyl (-CHz-CH2-), 1,1-ethanediyl ((-CH(CH3)-), 1,1-, l,2~, 1,3-
propanediyl and 1,1-, 1,2—, 1,3-, 1,4-butanediyl, with particular preference given to
methandiyl, 1,1-ethanediyl, 1,2—ethanediyl, opanediyl, 1,4-butanediyl.
As used herein, the term “cycloalkyl” refers to a saturated or partially saturated,
monocyclic, fused polycyclic, or Spiro polycyclic, carbocycle having from 3 to 12 ring
atoms per carbocycle. Illustrative es of cycloalkyl groups include the following
es: cyclopropyl, cyclobutyl, cyclpentyl and hexyl. Cycloalkyl may be
unsubstituted or substituted; exemplary substituents are provided in the definition for
alkyl and also include alkyl itself (e.g. ). A moiety like —(CH3)cyclopropyl is
considered substituted cycloalkyl.
As used herein, the term “aryl” refers to an ic homocyclic ring system (lie.
only Carbon as ring forming atoms) with 6 or more carbon atoms; aryl is preferably an
aromatic moiety with 6 to 14 ring carbon atoms, more preferably with 6 to 10 ring carbon
atoms, such as phenyl or naphthyl, preferably phenyl. Aryl may be unsubstituted or
substituted by one or more, preferably up to three, more preferably
up to two substituents
independently selected from the group ting of unsubstituted or substituted
heterocyclyl as described below, especially pyrrolidinyl, such as pyrrolidino,
oxopyrrolidinyl, such as oxopyrrolidino, C1-C7-alkyl-pyrrolidinyl, "2,5-di-(C1-
C7alkyl)pyrrolidinyl, such as 2,5-di-(C1-C7alkyl)-pyrrolidino, tetrahydrofuranyl, thio-
phenyl, C1-C7-alkylpyrazolidinyl, pyridinyl, C1-C7-alkylpiperidinyl, piperidino,
piperidino substituted by amino or N—mono— or -[lower alkyl, phenyl, C1-C7-
alkanoyl and/or phenyl-lower alkyl)-amino, unsubstituted or r alkyl tuted
piperidinyl bound Via a ring carbon atom, zino, lower alkylpiperazino, morpholino,
thiomorpholino, S-oxo—thiomorpholino or S,S-dioxothiomorpholino; C1-C7-alkyl, amino-
C1—C7-alkyl, N—Cl-C7-alkanoylamino-C1-C7-alkyl, N-C1-C7-alkanesulfonyl-amino-C1-C7-
alkyl, carbamoyl-Cl-Cralkyl, [N-mono- or N,N-di—(C1-C7—alkyl)-carbamoyl]-C1-C7-alkyl,
C1-C7-alkanesulfinyl-C1-C7—alkyl, C1-C7-alkanesulfonyl-C1-C7-alkyl, phenyl, naphthyl,
mono- to tri-[Cl-C7-alkyl, halo and/or cyano]-phenyl or mono- to tri-[Cl-C7-alkyl, halo
and/or cyano]-naphthyl; C3-Cg-cycloalkyl, mono- to tri-[C1-C7-alkyl and/or hydroxy]-C3-
Cg-cycloalkyl; halo, hydroxy, lower alkoxy, lower-alkoxy-lower alkoxy, (lower-alkoxy)-
lower alkoxy-lower alkoxy, halo-Cl-C7-alkoxy, phenoxy, yloxy, phenyl- or
naphthyl-lower alkoxy; amino-CI-C7-alkoxy, lower-alkanoyloxy, benzoyloxy,
naphthoyloxy, formyl (CHO), amino, N-mono- or -(C1-C7-a1kyl)-amino, C1-C7-
alkanoylamino, 01-C7-alkanesulfonylarnino, carboxy, lower alkoxy yl, e.g.;
phenyl- or naphthyl-lower alkoxycarbonyl, such as benzyloxycarbonyl; alkanoyl,
such as acetyl, benzoyl, naphthoyl, carbamoyl, N-mono- or substituted carbamoyl,
such as N-mono— or N,N-di-substituted carbamoyl wherein the substitutents are selected
from lower alkyl, (lower-alkoxy)-lower alkyl and hydroxy-lower alkyl; amidino, guanidi-
no, ureido, mercapto, lower alkylthio, phenyl— or naphthylthio, phenyl- or naphthyl-lower
alkylthio, lower phenylthio, lower alkyl-naphthylthio, halo-lower alkylmercapto,
sulfo (-SO3H), lower alkanesulfonyl, phenyl- or naphthyl-sulfonyl, - or naphthyl-
lower alkylsulfonyl, alkylphenylsulfonyl, halo-lower alkylsulfonyl, such as trifluorome-
thanesulfonyl; amido, benzosulfonamido, azido, azido-Cl-C7-alkyl, especially
azidomethyl, alkanesulfonyl, sulfamoyl, N-mono- or N,N-di-(C1—C7-alkyl)-
sulfamoyl, morpholinosulfonyl, thiomorpholinosulfonyl, cyano and nitro; where each
phenyl or naphthyl (also in phenoxy or oxy) mentioned above as substituent or
part of a substituent of substituted alkyl (or also of substituted aryl, cyclyl etc.
mentioned herein) is itself unsubstituted or substituted by one or more, e.
g. up to three,
preferably 1 or 2, substituents independently selected fi'om halo, halo-lower alkyl, such as
trifluoromethyl, hydroxy, lower alkoxy, azido, amino, - or —(lower alkyl
and/or C1-C7-alkanoyl)-amino, nitro, carboxy, lower-alkoxycarbonyl, carbamoyl,
cyano
and/or sulfamoyl.
The term “aryloxy” refers to a moiety comprising an
oxygen atom that is
substituted with an aryl group, as defined above.
The term “heteroaryl,” as used herein, represents a stable monocyclic or bicyclic
ring ofup to 7 atoms in each ring, wherein at least one ring is ic and contains from
1 to 4 heteroatoms selected from the group consisting of O, N and S. Heteroaryl groups
within the scope ofthis definition include but are not limited to: acridinyl, carbazolyl,
cinnolinyl, quinoxalinyl, pyrrazolyl, indolyl, benzotriazolyl, fixranyl, thienyl,
benzothienyl, benzofuranyl, quinolinyl, isoquinolinyl, oxazolyl, isoxazolyl, indolyl,
pyrazinyl, pyridazinyl, pyridinyl, pyrimidinyl, yl, tetrahydroquinoline. As with the
definition of heterocycle below, “heteroaryl” is also understood to include the N-oxide
derivative of any nitrogen-containing heteroaryl. In cases where the heteroaryl
substituent is bicyclic and one ring is non-aromatic or contains no heteroatoms, it is
understood that attachment is via the ic ring or via the heteroatom containing ring,
respectively.
As used herein, the term “heterocycle” or ocyclyl” refers to a heterocyclic
radical that is unsaturated (= ng the highest possible number of conjugated double
bonds in the ring(s)), saturated or partially saturated and is preferably a monocyclic or in
a broader aspect of the invention bicyclic, tricyclic or spirocyclic ring; and has 3 to 24,
more ably 4 to 16, most preferably 5 to 10 and most preferably 5 or 6 ring atoms;
wherein one or more, preferably one to four, especially one or two ring atoms are a
heteroatom (the remaining ring atoms therefore being carbon). The g ring (1'. e. the
ring connecting to the molecule) ably has 4 to 12, especially 5 to 7 ring atoms. The
term heterocyclyl also includes heteroaryl. The heterocyclic radical (heterocyclyl) may be
unsubstituted or substituted by one or more, especially 1 to 3, substituents independently
selected from the group consisting of the substituents defined above for tuted alkyl
and / or from one or more of the following substituents: oxo (=0), thiocarbonyl (=S),
imino(=NI-I), imino—lower alkyl. Further, heterocyclyl is especially a heterocyclyl radical
selected from the group consisting of oxiranyl, azirinyl, aziridinyl, 1,2-oxathiolanyl,
thienyl (= thiophenyl), furanyl, tetrahydrofuryl, pyranyl, thiopyranyl, thianthrenyl,
isobenzofuranyl, benzofuranyl, chromenyl, 2H-pyrrolyl, pyrrolyl, pyrrolinyl, pyrro-
lidinyl, imidazolyl, olidinyl, benzimidazolyl, pyrazolyl, pyrazinyl, lidinyl,
thiazolyl, isothiazolyl, dithiazolyl, oxazolyl, isoxazolyl, pyridyl, pyrazinyl, pyrimidinyl,
piperidinyl, piperazinyl, pyridazinyl, morpholinyl, thiomorpholinyl, (S-oxo or S,S-
dioxo)—thiomorpholinyl, indolizinyl, azepanyl, diazepanyl, ally azepanyl,
isoindolyl, 3H—indolyl, indolyl, benzimidazolyl, cumaryl, indazolyl, triazolyl, tetrazolyl,
purinyl, 4H-quinolizinyl, isoquinolyl, yl, tetrahydroquinolyl, tetrahydroisoquinolyl,
decahydroquinolyl, droisoquinolyl, benzofuranyl, dibenzofuranyl,
benzothiophenyl, dibenzothiophenyl, phthalazinyl, yridinyl, alyl,
quinazolinyl, quinazolinyl, cinnolinyl, pteridinyl, carbazolyl, beta-carbolinyl, phenanthri-
dinyl, acridinyl, perimidinyl, phenanthrolinyl, furazanyl, phenazinyl, hiazinyl,
azinyl, chromenyl, isochromanyl, chromanyl, benzo[l,3]dioxolyl and 2,3-
dihydro-benzo[l ,4]dioxinyI, each ofthese ls being unsubstituted or substituted
by one or more, preferably up to three, substituents ed from those mentioned above
for substituted aryl and/or from one or more of the following substituents: oxo (=0),
thiocarbonyl (=S), imino(=NH), imino-lower alkyl.
The term “heteroatoms” are atoms other than Carbon and Hydrogen, preferably
nitrogen (N), oxygen (0) or sulfur (S), in particular nitrogen.
2012/053559
Moreover, the alkyl, alkoxy, aryl, aryloxy and heteroaryl groups described above
can be “unsubstituted” or “substituted.” The term “substituted” is intended to describe
moieties having substituents replacing a hydrogen on one or more atoms, e.
g. C, O or N,
of a molecule. Such substituents can independently include, for example, one or more of
the following: ht or branched alkyl (preferably C1-C5), cycloalkyl (preferably
C3-C3), alkoxy (preferably C1-C6), thioalkyl (preferably C1-C6), alkenyl rably
C2-C6), alkynyl (preferably C2-C6), heterocyclic, carbocyclic, aryl (e.g., phenyl), aryloxy
(e.g., phenoxy), aralkyl (e.g., benzyl), aryloxyalkyl (e.g, phenyloxyalkyl),
arylacetamidoyl, alkylaryl, heteroaralkyl, alkylcarbonyl and arylcarbonyl or other such
acyl group, heteroarylcarbonyl, or heteroaryl group, (CR’R”)o.3NR’R” (e.g., -NH2),
(CR’R”)0_3CN (e.g., —CN), —NOz, halogen (e.g., -F, -Cl, -Br, or -I), (CR’R”)0-3C(halogen)3
_ (e.g., -CF3), (CR’R”)0-3CH(halogen)2, (CR’R”)0_3CH2(halogen), (CR’R”)0_3CONR’R”,
(CR’R”)O-3(CNH)NR,R”2 (CR’R”)o—3$(0)1.2NR’R”, (CR’R”)o-3CH0,
(CR’R”)0.30(CR’R”)0.3H, (CR’R”)0-3S(O)0.3R’ (e.g., ~SO3H, -OSO3H),
)¢30(CR’R”)0.3H (e.g., -CH20CH3 and -OCH3), )0_3S(CR’R”)0_3H
(e.g., -SH and -SCH3), (CR’R”)o-3OH (e.g., —OH), (CR’R”)MCOR’,
(CR’R”)0-3(substituted or unsubstituted phenyl), (CR,R”)0_3(C3-Cs cycloalkyl),
(CR’R”)0_3C02R’ (e.g., -C02H), or (CR’R”)0_3OR’ group, or the side chain ofany
lly occurring amino acid; wherein R’ and R” are each independently hydrogen, a
C1-C5 alkyl, C2-C5 alkenyl, C2-C5 alkynyl, or aryl group.
As used herein, the term “halogen” or “halo” refers to fluorine, bromine, chlorine
or iodine, in particular fluorine, chlorine. Halogen—substituted groups and es, such
as alkyl substituted by halogen (haloalkyl) can be mono-, poly- or per-halogenated.
The term “amine” or “amino” should be understood as being broadly d to
both a molecule, or a moiety or functional group, as lly understood in the art, and
may be primary, secondary, or tertiary. The term “amine” or ” includes
compounds where a nitrogen atom is covalently bonded to at least one carbon, hydrogen
or atom. The terms include, for example, but are not limited to, “alkyl amino,”
“arylamino,” “diarylamino,” “alkylarylamino,” “alkylaminoaryl,” “arylaminoalkyl,”
“alkaminoalkyl,” “amide,” ,” and “aminocarbony .” The term “alkyl amino”
comprises groups and compounds wherein the nitrogen is bound to at least one additional
W0 2012/117071
alkyl group. The term “dialkyl amino” includes groups wherein the nitrogen atom is
bound to at least two additional alkyl
groups. The term “arylamino” and “diarylamino”
include groups wherein the nitrogen is bound to at least one or two aryl
groups,
respectively. The term “alkylarylamino,” “alkylaminoaryl” or “arylaminoalkyl” refers to
an amino group which is bound to at least one alkyl group and at least
one aryl group.
The term “alkaminoalkyl” refers to an alkyl, alkenyl, or alkynyl
group bound to a
nitrogen atom which is also bound to an alkyl group.
Examples
Abbreviations
- The following abbreviations are used in the figures and text: THF
(tetrahydrofuran); RT (room temperature); iPerH (diisopropylamine); iPerLi (lithium
diisopropylamide); LDA (lithium diisopropylamide); H2804 ric acid); H20 (water);
IPA opyl acetate); NaCl (sodium chloride); MsCl nesulfonyl chloride); NaH
m hydride); n-BuLi (n-butyllithium); SF4 (sulfur uoride); HCl (hydrochloric
acid); HF (hydrofluoric acid).
Synthesis Procedures
Scheme 1
LPqNH
n-hexyllithium
(in n—hexane) 1. Me
THF l Me‘o--L'I
/ CF I n
~15°c N 3 Me»: 0
Me Me Me Me
(1 )
i-Pl'zNLi \ 15Maq. H2304 \
(in THF/n—hexane) I
2. O N/ CF3 luene N/ CF3
MeJL'flDMe Me Me 0°C Me Me
(2) (3)
To a solution of 1.5 equiv. of lithium diisopropylamide in THF at ~15 °C,
freshly prepared from n-hexyllithium and diisopropylamine, was added a solution of
1.0 equiv. of building block (1) in THF over 30 min. The resulting deep brown-red
W0 2012/117071
solution was then d at ~15 °C for 30 min. Subsequently, a solution of 1.15 equiv.
of Weinreb amide (2) in THF was added over 30 min, and the reaction stirred at —15 °C
for 1 h before being transferred onto a mixture of 1.5 molar
aqueous sulfuric acid and
toluene at 10 °C. The biphasic mixture was vigorously stirred at room temperature for
min. Care was taken that the aqueous layer stayed at 2 < pH < 4, preferably pH 3.
After phase tion, the organic layer was washed with water, then concentrated at
50 °C under vacuum to ca. 15-20% of its original volume to provide a solution of crude
ketone (3) in e.
Scheme 2
s 'HBr
abs. Ethanol, 40 °C \
+ A
/ 01:3 HzN NHz l
N CF3
2.|PA,0°C N
Me Me Me Me
(3) (5)
A solution of 1.0 equivalents of crude (3) in toluene is diluted with te
ethanol at room temperature, then 1.10 equivalents ofthiourea was added. The yellow
suspension is heated to 40 °C, and imately 1.01 equivalents of solid N—
bromosuccinimide was added in portions over 30 min. After complete addition, the
resulting red, clear solution was stirred at 40 °C for l h. The reaction e was
diluted with isopropyl acetate (IPA), and the fine, yellow—orange suspension was cooled
to 0 °C over 1.5 h. Filtration over a sintered glass filter and subsequent washing
provided the wet reaction product (5), which was finally dried at 50 °C under vacuum.
WO 17071
Scheme3
NH2 NH2
1 ' 0
N- N—
. I I
\ S \ s Clio
Me Me
‘HBr
Pyridine. _ (7)
\ \ THF. 40 no r
I ._____, I
N/ CF3 THF! RT N/ CF3
2. wash with saturated
Me Me Me Me aqueous NaCl
(5) (6)
O N
N— o—Q 1.411336% (IX) N- _<\o o
\ 3 H 0
Me \ 3
\ THF/H20. 60 °C \
I _. I
N’ CF3
2. add toluene. N’ CF3
Me Me distill Off THF, Me Me
then add water
(8) (10)
To a yellow suspension of 1.0 lents of compound (5) in THF at room
temperature was added 2.0 equivalents ofpyridine. The reaction mixture was heated to
40 °C, then a solution of 1.0 lents ofphenyl chloroformate (7) in THF was added
over 30 min. After stirring at 40 °C for 1 h, the reaction was cooled to RT, then saturated
aqueous NaCl solution was added, and the biphasic e was stirred at RT for 10 min
before phase separation. The organic layer was heated to 60 °C, then a solution of 1.0
equivalents of L-prolinamide (IX) in water was added over 30 min. The reaction was
stirred at 60 °C fer 2 h, then the reaction mixture was cooled to 50 °C, then toluene was
added, followed by removal of THF via distillation under vacuum. The resulting
suspension was treated with water, and the reaction mixture was stirred at 50 °C for 30
min, before being cooled to 10 °C over 2 h. After stirring at 10 °C for another 30 min, the
off-whitesuspension was filtered, and the filter cake washed with toluene, then dried at
50 °C under vacuum to give (10).
Scheme 4
TMSCF3
\ NaOAc
l K2C03
N/ Me DMSO OTMS MeOH. RT
RTto 45°C
0 NeM CF3 NMe CF3
Me Me
MSCI, NaH \ AIM63 \
I I
THF. / OMs / CF
N cyclohexane, RT a
RT“ 4° C
Me CFa Me Me
(d) (1)
4-Meth l 2 2 uoro—1-meth I-l-trimeth lsilan lox ridine (b). To a fine,
white sion of sodium acetate (96.0 g, 117 mmol, 1.0 equiv.) in 1 L DMSO was
added yl-4—methylpyridine (158 g, 117 mmol, 1.0 equiv.). After dilution with
another 0.5 L DMSO, trimethyl—trifluoromethylsilane (375 g, 264 mmol, 2.2 equiv.) was
added over 75 minutes. During the addition, the reaction vessel was placed in a cooling
bath at 10 °C to keep the internal ature between 20-25°. The resulting dark
suspension was stirred at room temperature over night, then quenched carefully by
addition of 1.5 L water over 20' minutes. During the on of water, the reaction vessel
was placed in a cooling bath at -5 °C to keep the internal temperature between 10-25 °C.
After stirring at room temperature for 45 minutes, the mixture was d with 3 L ethyl
acetate and stirred for another 15 minutes. The phases were separated, and the water
layer was extracted with 2L ethyl acetate. The combined organic phases were washed
with 3 L saturated aqueous NaHCO3, dried over MgSO4, filtered and concentrated in
vacuo to give 346 g (106%, 88.6 area°o by HPLC) oftrifluoromethyl compound (b) as a
brown, intensively smelling oil.
1,1,1-Trifluoro§4-methylpyridinyl[propan-Z-ol (c). To a solution of 4-methyl
(2,2,2-trifluoromethyltrimethylsilanyloxy-ethyl)pyridine (b) (346 g, 125 mmol, 1.0
equiv.) in 1.5 L MeOH at room temperature was added solid K2CO3 (344 g, 249 mmol,
2.0 ). The resulting beige suspension was stirred at room temperature for 1 hour,
then filtered over filter paper. The filtrate was concentrated in vacuo to give a solid,
intensively smelling residue. The residue was dissolved in 1 L ethyl acetate and washed
with water (2 x 1 L). After drying over MgSO4 and ion, tration in vacuo
provided 252 g (98%) of alcohol (c) as an oil.
1,1,1-Trifluorog4-methylpgidin-2—yl)propan-Z-yl methanesulfonate (d). To a
suspension ofNaH (60% in l oil, 23.4 g, 585 mmol, 1.5 equiv.) in l L THF at 0 °C
was added a solution of 1,1,l~trifluor02-(4-methylpyridinyl)propanol (c) (80 g, 390
mmol, 1.0 equiv.) in 200 m1 THF dropwise over 34 minutes. Gas evolution occurred, and
the reaction mixture turned brownish. The reaction was warmed to 40 °C and stirred at
40 °C for 45 s, when gas evolution had ceased. After cooling to room temperature,
a solution of methanesulfonyl chloride (45.6 ml, 585 mmol, 1.5 equiv.) in 50 ml THF was
added dropwise over 30 minutes. The internal temperature rose to 36 °C, and the
reaction mixture turned into a light brown suspension. The reaction mixture was warmed
to 40 °C and stirred at this temperature for 15 minutes, then cooled to room temperature
and further stirred over night. The reaction'was carefully quenched by addition of 750 ml
water with cooling in an ice bath. The resulting brown biphasic mixture was stirred at
room temperature for 30 s, then the phases were separated. The aqueous layer was
extracted with 750 ml ethyl acetate, and the combined c phases were washed with
saturated aqueous NaHCO3. Drying over MgSO4, filtration and concentration in vacuo
provided a beige solid. The residue was redissolved in 300 ml ethyl e to give a
turbid solution, then filtered over a plug of silica gel (120 g) and eluted with 600 ml ethyl
acetate. Concentration in vacuo provided a beige solid which was redissolved in 400 ml
heptane and 150 ml ethyl acetate at reflux. After hot filtration over a fritted funnel, the
product llized at 0 °C. The crystals were collected by ion, washed with cold
heptane/ ethyl acetate 8:3 (2 x 80 ml) and dried (50 °C, 10 mbar) over night to give 94.0
g (85%) of mesylate (d) as white crystals.
yl1l,1,1-trifluoromethylpropan—2—ylzpyridine (1). To a sion of 1,1,1-
trifluoro(4-methylpyridinyl)propan-2—y1methanesulfonate (d) (5,68 g, 20.1 mmol,
1.0 equiv.) in 60 ml cyclohexane at 10 °C was added AlMe3 in hexane (2.0 M, 15.0 ml,
mmol, 23.0 equiv.) dropwise over 15 minutes. The reaction was warmed at room
temperature and stirred at room temperature for 3 hours. The mixture was quenched by
l addition to 100 ml water at 0 °C and stirred at room temperature for 15 minutes.
Afier filtration over a plug of ck and elution with ethyl acetate, the phases were
separated. The aqueous layer was ted with ethyl acetate, and the combined c
phases were washed with water and saturated aqueous NaCl. After drying over Na2S04,
filtration and concentration in vacuo provided a slightly brownish oil, which was purified
by chromatography on siliga gel (hexane/ TBME 9: 1) to provide 1.15 g (28%) of the
desired compound (1) as a colorless oil.
Schemes
Me Me Me
\ n-BuLi, Mel; \ NaOH \
l ———>| _.l
N/ diethylcarbonate N/ (30215t N/ 002Na
Me Me Me Me
(6) (r) (9')
SF4, HF \
/ CF3
Me Me
To a solution of n-butyllithium (2.04 equiv.) in 2-methyltetrahydrofuran at
maximum —40 °C was added a solution of2,4-dimethylpyridine (e) (2.02 equiv.) in 2-
methyltetrahydrofuran over 60 min, keeping the temperature below —30 °C. The reaction
e was stirred for 30 min at maximum —30 °C. A on of diethyl carbonate
(1.00 equiv.) in 2-methyltetrahydrofuran was added over 60 min, keeping the temperature
below —30 °C. The reaction was warmed to room temperature, and then d at this
temperature for 5 h. After cooling to 0 °C, methyl iodide (2.15 equiv.) was charged over
40 min, keeping the temperature below 25 °C. The reaction was further d at room
temperature for 1 h, then 1 M HCl was added, and the pH was adjusted to a value ofpH
8-9. After stirring for 15 min, the phases were separated, and the organic phase was
washed with water. Distillation at 35 °C under vacuum then provided crude dimethylated
ester (1‘). Ester (1’) was subsequently added to a solution of sodium hydroxide (1.05
equiv.) in ethanol at 78 °C over 2 h. More ethanol was added, and the reaction was
stirred at 78 °C for 10 h. The volume was reduced to approximately 50% by distillation
under normal pressure. After cooling to room temperature, tert-butyl methyl ether was
added, and the reaction mixture was stirred at this temperature for 30 min. Filtration was
med after cooling to 5-10 °C, and the filter cake was washed with dichloromethane.
The wet t was dried at 60-70 °C under vacuum to give sodium carboxylate (g').
Compound (g') was reacted with sulfur tetrafluoride and hydrofluoric acid to afford
compound (1).
Claims (16)
1. A process for making a compound of formula (X): comprising the following steps: M: contacting a compound of formula (I) with a t tetrahydrofuran and a base lithium ropylamide, and contacting the resulting mixture with a compound of formula (II) at an internal temperature of less than about -5°C to about -15°C, such that a compound of formula (III) is ed: CH3 R2 \ 0 \ / )L ,OCHs ' N R1 R2 'fl N R1 (I) (II) (”I) Step B: contacting a compound of formula (III) with thiourea, in a reaction mixture comprising a solvent selected from toluene, l solvent, ethanol or a combination thereof and an oxidizing agent N-bromosuccinimide or 1,3-dibromo-5,5-dimethylhydantoin, such that a compound of formula (V) is produced: - HX N R1 Step C: contacting a compound of formula (V) with a compound of a (VII), in a reaction mixture comprising a solvent tetrahydrofuran and a base amine, such that a compound of formula (VIII) is produced: N/ O O \ A ' R3 R4 N R1 (VII) (VIII) Step D: contacting a compound of formula (VIII) with the compound of formula (IX), 0 H (IX) in a reaction e comprising a solvent selected from tetrahydrofuran, water or a combination thereof, such that a nd of formula (X) is produced wherein R1 is a branched or linear C1-C7 alkyl, which may be optionally substituted one or more times with ium, n, or C3-C5 cycloalkyl, R2, is methyl R3 is halogen or heteroaryl, R4 is C6-C14 aryloxy or heteroaryl and X is a halide.
2. The process of claim 1, wherein the resulting mixture of a compound of formula (I) and a solvent tetrahydrofuran and a base lithium diisopropylamide of Step A is contacted with a compound of formula (II) at an internal temperature of about -15°C.
3. The process of claim 1, wherein the t of Step B comprises toluene and ethanol.
4. The process of claim 1, wherein the t of Step D comprises tetrahydrofuran and water.
5. The process of claim 1, wherein the base of Step C is pyridine.
6. The process of any one of claims 1 to 5, wherein the solvent of Step B ses toluene and ethanoland the solvent of Step D comprises tetrahydrofuran and water. ‘f CF3 7<CH3
7. The process of any one of claims 1 to 6, wherein R1 is H30 , R2 is methyl, R4 is phenoxy, R3 is chlorine and X is bromine.
8. A process for making the compound of formula (10): HN grim N:( o O N/ CF15 H30 CH3 (10) comprising the ing steps: m: contacting the compound of formula (1) with a solvent tetrahydrofiiran and a base lithium ropylamide, and contacting the resulting mixture with the compound of formula (2) at an internal temperature of less than about -5°C to about -15°C, such that the compound of formula (3) is produced: CH3 H3C \ 0 N/ CF3 HacJLNpcm l N/ CF3 H3C CH3 CH3 - H3C CH3 (1) (2) (3) ; Step B: contacting the compound of formula (3) with ea, in a reaction mixture comprising a solvent selected from toluene, ethanol or a combination thereof and an oxidizing agent N-bromosuccinimide, such that the compound of formula (5) is produced: Step C: contacting the compound of formula (5) with the compound of a (7), in a reaction mixture comprising a solvent tetrahydrofuran and a base amine, such that the compound of formula (8) is produced: N/ 0 <1 ° '\ O/U\Cl N/ CF" H30 CH3 (7) (3) ;and Step D: contacting the compound of formula (8) with the compound of formula (IX) o H (IX) in a reaction mixture comprising a solvent selected from tetrahydrofuran, water or a combination thereof, such that the compound of formula (10) is produced.
9. The process of claim 8, wherein the resulting mixture of a compound of formula (1) and a solvent tetrahydrofuran and a base lithium diisopropylamide of Step A is contacted with a compound of formula (2) at an internal temperature of about -15°C.
10. The compound according to formula (1): N/ CF3 H30 CH3
11. The process of claim 1, substantially as herein described with reference to any one of the Examples thereof.
12. The process of any one of claims 1 to 7, substantially as herein bed.
13. The s of claim 8, substantially as herein bed with reference to any one of the Examples thereof.
14. The process of claim 8 or 9, substantially as herein described.
15. The compound of claim 10, substantially as herein described with reference to any one of the Examples thereof.
16. The nd of claim 10, substantially as herein described.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161448774P | 2011-03-03 | 2011-03-03 | |
US61/448,774 | 2011-03-03 | ||
PCT/EP2012/053559 WO2012117071A1 (en) | 2011-03-03 | 2012-03-01 | Synthesis of 2-carboxamide cycloamino urea derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ614173A NZ614173A (en) | 2015-04-24 |
NZ614173B2 true NZ614173B2 (en) | 2015-07-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9776966B2 (en) | Synthesis of 2-carboxamide cycloamino urea derivatives | |
AU2009300869B2 (en) | Pyridine and pyrimidine based compounds as Wnt signaling pathway inhibitors for the treatment of cancer | |
AU2015223049B2 (en) | Heterocyclic compounds as NaV channel inhibitors and uses thereof | |
KR20160127761A (en) | Hepatitis c virus inhibitors and uses thereof in preperation of drugs | |
WO2003086398A1 (en) | Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity | |
NZ580237A (en) | Compounds with anti-cancer activity | |
EP1494672A1 (en) | Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity | |
PH12015502801B1 (en) | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate | |
AU2008338273A1 (en) | Viral polymerase inhibitors | |
JP2022549222A (en) | NOVEL UREA HAVING ANDROGEN RECEPTOR-DELAYING ACTIVITY AND USE THEREOF | |
KR20180049056A (en) | Tricyclic condensed pyridine-2-one derivatives and their use as BRD4 inhibitors | |
CN110862390A (en) | Fused tricyclic compound and application thereof in medicines | |
CN112469716A (en) | Dihydropyrimidine derivatives and use thereof | |
NZ614173B2 (en) | Synthesis of 2-carboxamide cycloamino urea derivatives | |
CA3211181A1 (en) | Wee1 inhibitor and use thereof | |
CN103724352B (en) | A kind of intermediate of DPP IV inhibitor, its preparation method and the method for DPP IV inhibitor is prepared by it | |
CN117396462A (en) | Antiviral compounds | |
WO2022112140A1 (en) | Aryloxazolo spiral ring derivatives for the treatment and prophylaxis of hepatitis b virus infection | |
CA3002920A1 (en) | Method for removing dimethoxybenzyl group |